PsyBio Therapeutics Augments Intellectual Property Portfolio with Filing of Next Novel Psychedelic Compositions and… Jul 13, 2021
COMPASS Pathways Teams with UK Institutions to Research Innovations in Mental Health Care Jul 7, 2021
Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary Formulations Jul 7, 2021
Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology Jul 6, 2021
The Latest On Psybio Therapeutics: CEO Evan Levine Comments On Maxim Group Buy Rating, European Research, And More Jul 6, 2021
